Chemical control of breathing in asthmatic patients with a history of acute asthma attacks (AA)

M. Franczuk, L. Radwan, J. Kowalski (Warsaw, Poland)

Source: Annual Congress 2001 - Control of breathing and sleep-disordered breathing
Session: Control of breathing and sleep-disordered breathing
Session type: Thematic Poster Session
Number: 634
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Franczuk, L. Radwan, J. Kowalski (Warsaw, Poland). Chemical control of breathing in asthmatic patients with a history of acute asthma attacks (AA). Eur Respir J 2001; 16: Suppl. 31, 634

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010


Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001

Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma
Source: Eur Respir J 2002; 19: 846-852
Year: 2002



Allergen sensitization in patients with cough variant asthma (CVA)
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

Sensitized allergens in cough variant asthma (CVA) and classic asthma with wheezing (CA)
Source: Eur Respir J 2004; 24: Suppl. 48, 137s
Year: 2004

Relationship between benralizumab exposure and asthma exacerbation rate for patients with severe asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Is the asthma control questionnaire (ACQ) usefull during acute moderate to severe (AMS) asthma exacerbations (AE)?
Source: Eur Respir J 2004; 24: Suppl. 48, 591s
Year: 2004

A comparison of the frequency of cough with laughter in asthmatic and non asthmatic patients
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012


Greater severity of new-onset asthma in allergic subjects who smoke
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010


The relationship of sinusitis with acute exacerbations of COPD and acute asthmatic attack
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Treatment of bronchial asthma and wheezing disorders: acute
Source: ERS Skills Course 2016
Year: 2016

Predictors for asthma onset from cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002

Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitis
Source: Eur Respir J, 53 (5) 1801921; 10.1183/13993003.01921-2018
Year: 2019



Treating exacerbations of asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients
Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders?
Year: 2010


Treating acute severe asthma attacks in children: using aminophylline
Source: Breathe, 16 (4) 200081; 10.1183/20734735.0081-2020
Year: 2020



Time to exacerbation in the ²real-life² management of asthma (GPRD-REALITY)
Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases
Year: 2008


Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009

Omalizumab (Xolair®) reduces exacerbations in patients with moderate-to-severe persistent allergic asthma independent of former smoking status
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Current control, airway inflammation, and subsequent exacerbation in patients with asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010